Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514
Name: Drug, bio-affecting and body treating compositions >
Description: Class 514 is an integral part of Class 424. It incorporates all the definitions and rules as to subject matter of Class 424.


Class Number Class Name No. of Patents
514/810

Addiction

99
514/811

Alcohol

150
514/812

Narcotic

150
514/813

Tobacco

131
514/805

Adrenocorticotropic hormone or derivatives

32
514/814

Anemia

106
514/815

Sickle cell

44
514/816

Anesthetic, general

92
514/818

Anesthetic, local

106
514/817

Anesthetic, topical

138
514/819

Antacid, oral

84
514/820

With antiflatulent

21
514/821

Antiarrhythmic

421
514/822

Anticoagulation

469
514/823

Antidote

84
514/824

Arteriosclerosis

607
514/825

Arthritis

673
514/826

Asthma

800
514/827

Astringent, nonfacial

24
514/828

Topical for the skin

70
514/829

Bite or sting

41
514/831

Animal (nonpoisonous)

7
514/830

Insect

39
514/833

Blood plasma extender

87
514/832

Blood substitute

172
514/959

Breathing gases

47
514/808

Calcitonin or derivatives

61
514/962

Capsule (e.g., gelatin, etc.)

306
514/963

Microcapsule-sustained or differential release

316
514/835

Caries

94
514/975

Characterized by the designated surfactant used

357
514/836

Chelate

221
514/837

Cholera

18
514/838

Cirrhosis

33
514/834

Coagulant

73
514/801

Collagen, gelatin or derivatives thereof

194
514/839

Contact lens treatment

114
514/840

Chemical sterilizing

114
514/974

Containing designated ingredient to reduce noxious effects of active ingredient (e.g., taste masking, odor reducing, etc.)

253
514/970

Containing designated ingredient to stabilize an active ingredient

486
514/971

Crystallization point depressant or cold stabilizer containing

47
514/973

Sulfur compound additive as stabilizer (e.g., sulfites, etc.)

70
514/972

Ultraviolet light stabilizer containing

92
514/841

Contraceptive

136
514/843

Female (mammal)

230
514/842

Non-mammal

17
514/844

Cosmetic, facial

1363
514/846

Cleansing cream or lotion

598
514/848

Facial astringent

122
514/847

Facial moisturizer

693
514/845

Liquid make-up

284
514/849

Cough and cold preparation

119
514/850

Antitussive

44
514/851

Cystic fibrosis

110
514/852

Dandruff

113
514/853

Decongestant

62
514/855

Expectorant

38
514/854

Vasoconstrictor

18
 

Dermatitis

 
514/859

Acne

552
514/858

Athlete's foot

77
514/860

Cellulitis

62
514/865

Diaper rash

80
514/861

Eczema

276
514/862

Poison (ivy, oak, sumac)

78
514/863

Psoriasis

541
514/864

Seborrhea

209
514/769

Designated inorganic nonactive ingredient or elemental material other than water

146
514/771

Oxygen gas containing

22
514/770

Siliceous or calcareous material (e.g., clay, earth, etc.)

305
514/1

Designated organic active ingredient containing (doai)

323
 

Designated organic active ingredient containing (doai)

 
514/152

3,10-dihydroxy-2-naphthacene carboxamide or derivative (e.g., tetracycline, etc.) doai

251
514/154

With an additional active ingredient (excludes reaction product or complex)

64
514/153

With stabilizer or preservative

28
514/167

9,10-seco- cyclopentanohydrophenanthrene ring system (e.g., vitamin d, etc.) doai

543
514/168

With a vitamin type active ingredient

154
514/150

Acyclic nitrogen double bonded to acyclic nitrogen, acyclic nitrogen triple bonded to acyclic nitrogen or azide doai

243
514/151

Acyclic c-n=n-n containing

97
514/693

Aldehyde doai

152
514/699

Benzene ring containing

85
514/701

Acyclic carbon to carbon unsaturation

33
514/700

Polycyclo ring system

37
514/703

Carbon to carbon unsaturation

101
514/694

Formaldehyde

45
514/696

With alcohol

18
514/697

With nitrogen containing compound

10
514/695

With polycyclo compound

4
514/704

Nitrogen containing

13
514/705

Plural c=o groups

81
514/702

Sulfur containing

23
514/698

With preservative or stabilizer

37
514/149

Azoxy doai

40
514/64

Boron containing doai

183
514/724

C-o-group (e.g., alcohol, alcoholate, etc.) doai

467
514/729

Alicyclic ring containing

268
514/730

Benzene ring containing

187
514/731

C of c-o- group is nuclear c of a benzene ring (e.g., phenol, phenolate, etc.)

308
514/733

Acyclic carbon to carbon unsaturation

97
514/736

Additional benzene ring containing

88
514/737

Nuclear halogenated

61
514/732

Polycyclo ring system (e.g., naphthols, etc.)

127
514/734

Two or more separate aryl-o-groups

93
514/735

Nuclear halogenated

30
514/739

Carbon to carbon unsaturated

201
514/726

Diphenyl-substituted acyclic alcohol or alcoholate

44
514/727

Nitrogen containing

113
514/728

C of c-o- group is nuclear c of a benzene ring (e.g., phenol, phenolate, etc.)

68
514/738

Polyhydroxy

276
514/725

Vitamin a compound or derivative

493
514/23

Carbohydrate (i.e., saccharide radical containing) doai

1350
514/53

Dissacharide

641
514/62

Glucosamine or derivative

355
514/42

N-glycoside

279
514/43

Nitrogen containing hetero ring

369
514/52

Phosphorus containing (e.g., vitamin b12, etc.)

244
514/44

Polynucleotide (e.g., rna, dna, etc.)

3040
514/45

Purines (including hydrogenated) (e.g., adenine, guanine, etc.)

491
514/46

Adenosine or derivative

590
514/47

Phosphorus containing

353
514/48

Phosphorus containing

202
514/49

Pyrimidines (including hydrogenated) (e.g., cytosine, etc.)

468
514/50

2,4-diketone pyrimidine or derivative (e.g., uracil, etc.)

482
514/51

Phosphorus containing

241
514/25

O-glycoside

1130
514/26

Cyclopentanohydrophenanthrene ring system

257
514/35

Oxygen of the saccharide radical bonded directly to a cyclohexyl ring

106
514/36

Two or more nitrogen atoms bonded directly to the cyclohexyl ring

78
514/37

The nitrogen atoms are in n-c(=n)-n groups (e.g., streptomycin, etc.)

82
514/40

Two saccharide radicals bonded through only oxygen to 4- and 6- positions of the cyclohexyl ring

98
514/41

Kanamycin or derivative

73
514/38

Two saccharide radicals bonded through only oxygen to adjacent ring carbons of the cyclohexyl ring

42
514/39

Three or more saccharide radicals (e.g., neomycin, etc.)

110
514/27

Oxygen of the saccharide radical bonded directly to a nonsaccharide hetero ring or a polycyclo ring system which contains a nonsaccharide hetero ring

376
514/28

The hetero ring has 8 or more ring carbons

125
514/31

The hetero ring has 20 or more ring carbons (e.g., nystatin, etc.)

166
514/29

The hetero ring has exactly 13 ring carbons (e.g., erythromycin, etc.)

435
514/30

The hetero ring has exactly 15 ring carbons

264
514/33

Oxygen of the saccharide radical bonded directly to a polycyclo ring system of three or more carbocyclic rings

137
514/34

Oxygen of the saccharide radical bonded directly to a polycyclo ring system of four carbocyclic rings (e.g., daunomycin, etc.)

336
514/32

Oxygen of the saccharide radical bonded to a nonsaccharide hetero ring by acyclic carbon bonding

68
514/54

Polysaccharide

1893
514/57

Cellulose or derivative

319
514/55

Chitin or derivative

262
514/59

Dextran or derivative

259
514/58

Dextrin or derivative

495
514/56

Heparin or derivative

447
514/60

Starch or derivative

265
514/61

Tri- or tetrasaccharide

227
514/24

S-glycoside

212
514/169

Cyclopentanohydrophenanthrene ring system doai

451
514/172

Hetero ring containing

236
514/175

-c(=o)-o-is part of a hetero ring (e.g., lactone, etc.)

87
514/174

-o-c-o- is part of a hetero ring (e.g., acetonide, etc.)

162
514/176

Nitrogen containing hetero ring

246
514/173

Spiro ring system

99
514/177

Oxygen double bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system

487
514/178

Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system

655
514/181

21-position substituted

143
514/179

Modified c-ring (except methyl in 13-position) (e.g., double bond containing, substituted, etc.)

611
514/180

9-position substituted

274
514/182

Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system

883
514/170

Plural compounds containing cyclopentanohydrophenanthrene ring systems

315
514/171

With additional active ingredient

570
514/506

Ester doai

218
514/509

(o=)n(=o)-o-c containing (e.g., nitrate ester, etc.)

91
514/513

C-c(=x)-x-c containing (x is chalcogen and at least one x is other than oxygen)

251
514/514

Carbon bonded to -ncx or -xcn (e.g., cyanate, thiocyanate or isothiocyanate, etc.) (x is chalcogen)

121
514/516

Containing plural -ncx or -xcn groups or a cyano

35
514/515

With an additional active ingredient

54
514/519

Cyano or isocyano bonded directly to carbon

119
514/526

Acyclic

65
514/527

C=o other than as ketone or aldehyde

36
514/528

C(=o)n containing

82
514/520

Benzene ring containing

271
514/523

Additional nitrogen other than cyano

201
514/524

The cyano is bonded directly to a benzene ring

206
514/521

C=o other than as ketone or aldehyde

521
514/522

The cyano is bonded directly to a benzene ring

391
514/525

Two or more of the cyano groups

100
514/510

Polycyclo ring system

426
514/511

Two of the cyclos share at least three ring members (i.e., bridged)

56
514/507

R-c(=x)-n-x-c containing (e.g., hydroxamic acid ester, etc.) (r is c or h and x is chalcogen)

74
514/517

S-x-c containing (e.g., sulfates, etc.) (x is chalcogen)

231
514/518

S of s-x-c attached directly to a benzene ring

95
514/512

X-c(=x)-x containing (e.g., carbonic acid ester, thiocarbonic acid ester, etc.) (x is chalcogen)

168
514/508

X-c=n containing (e.g., imidoester, etc.) (x is chalcogen)

77
514/529

Z-c(=o)-o-y wherein z is hydrogen or an organic radical bonded to the c(=o) by a carbon and y is an organic radical bonded to the oxygen by a carbon

356
514/530

Z contains a cyclopentyl or cyclopentene ring

627
514/531

Z contains a cyclopropyl or cyclopropene ring

517
514/532

Z-c(=o)-o-y, wherein z contains a benzene ring

502
514/544

C(=o)o attached directly through the carbon to a benzene ring

300
514/533

Compound contains two or more c(=o)o groups indirectly bonded together by only conalent bonds

521
514/545

Ketone in z radical

99
514/543

Z forms a phenoxy alkyl or phenoxy alkenyl radical

165
514/534

Z or y radical contains a nitrogen atom

379
514/538

Nitrogen bonded to carbon in z moiety

524
514/541

Aldehyde or ketone in z or y radical

84
514/540

Nitrogen in y moiety

103
514/539

Plural separated benzene rings in z moiety

483
514/542

Z radical contains two or more nitrogen atoms at least one of which forms a c(=x)n group (x is chalcogen)

160
514/535

The nitrogen of the z radical is directly bonded to a benzene ring which is directly bonded to the c(=o) group

385
514/537

With an additional active ingredient

73
514/536

With an agent to enhance topical absorption or with a stabilizing agent

46
514/546

Zc(=o)oy, wherein z is an acyclic radical bonded to the c=o by a carbon and y is an organic radical bonded to the oxygen by a carbon

668
514/547

Compound contains two or more c(=o)o groups

567
514/548

Ring is alcohol moiety

282
514/552

Z contains an unbroken chain of at least seven carbon atoms bonded directly to the c(=o) group

359
514/549

Z radical contains carbon to carbon unsaturation

409
514/551

Z radical contains nitrogen

189
514/550

Z radical contains sulfur or halogen

155
514/715

Ether doai

109
514/722

Acyclic

96
514/723

Plural oxygens

193
514/717

Benzene ring containing

217
514/718

Plural oxygens

183
514/720

Acyclic carbon to carbon unsaturation

117
514/719

Alicyclic ring

78
514/721

Plural benzene rings

191
514/716

Nitrogen containing

100
514/743

Halogenated hydrocarbon doai

64
514/760

Bromine and chlorine as only halogens

6
514/761

Bromine and fluorine as only halogens

14
514/747

Carbocyclic

41
514/751

Benzene ring containing

29
514/752

Alkyne

12
514/754

Plural benzene rings

26
514/753

Polycyclo ring system

15
514/755

Polycyclo ring system

29
514/756

Bicyclo

34
514/748

Two benzene rings directly attached to an acyclic hydrocarbon or acyclic halogenated hydrocarbon (e.g., d.d.t., etc.)

22
514/749

Fluorine containing

26
514/750

With organic ether or -oh containing compound non-doai

5
514/758

Chlorine as only halogen

22
514/759

Fluorine as only halogen

72
514/757

Two or more halogenated hydrocarbons

34
514/744

Unsaturated aliphatic compound

41
514/745

Alkyne

11
514/746

Plural halogenated hydrocarbon compounds

37
514/492

Heavy metal containing doai

551
514/503

Antimony or bismuth

60
514/504

Arsenic

39
514/505

Cadmium or chromium

94
514/499

Copper

245
514/500

With an additional active ingredient

130
514/495

Gold or silver

98
514/502

Iron

244
514/498

Lead

20
514/496

Mercury

40
514/497

Nitrogen containing

16
514/501

Nickel or cobalt

116
514/493

Tin

167
514/494

Zinc

315
514/183

Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai

1461
514/192

1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.)

267
514/195

3-position substituent contains -cooc- group

162
514/194

6,6-di-substituted

55
514/197

6-position substituent contains carbocyclic ring

108
514/198

Ampicillin per se or salt thereof

79
514/199

Penicillin g per se or salt thereof (e.g., procaine pencillin g, etc.)

88
514/196

6-position substituent contains hetero ring

126
514/193

Spiro or additional polycyclo ring system

78
514/200

1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.)

177
514/201

7,7-di-substituted

163
514/202

Additional hetero ring

353
514/203

3-position substituent contains pyridine ring

181
514/204

3-position substituent contains sulfur

154
514/206

7-position substituent contains hetero ring

377
514/205

The additional hetero ring is part of a polycyclo ring system

72
514/207

Alkyl, hydroxyalkyl, alkoxyalkyl or alkanoyloxyakyl bonded directly to 3-position

140
514/209

Alkyl, hydroxyalkyl, alkoxyalkyl, or alkanoyloxyakyl bonded directly to 3-position

70
514/208

Sulfur containing substituent

58
514/191

Aluminum (including salts)

54
514/359

Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.)

557
514/383

1,2,4-triazoles (including hydrogenated)

1380
514/384

Chalcogen bonded directly to the triazole ring

314
514/403

1,2-diazoles

456
514/404

Divalent chalcogen or acyclic nitrogen double bonded directly to ring carbon of the diazole ring, or tautomeric equivalent

282
514/405

Polycyclo ring system having the diazole ring as one of the cyclos

123
514/406

Pyrazoles

876
514/407

Chalcogen or nitrogen bonded directly to the pyrazole ring by nonionic bonding

529
514/378

1,2-oxazoles (including hydrogenated)

717
514/380

Chalcogen or nitrogen bonded directly to ring carbon of the oxazole ring

318
514/379

Polycyclo ring system having the oxazole ring as one of the cyclos

218
514/372

1,2-thiazoles (including hydrogenated)

683
514/373

Polycyclo ring system having the thiazole ring as one of the cyclos

340
514/385

1,3-diazoles

307
514/401

2-imidazolines

242
514/402

Additional hetero ring

138
514/386

Divalent chalcogen or acyclic nitrogen double bonded directly to ring carbon of the diazole ring, or tautomeric equivalent

147
514/392

Divalent chalcogen or acyclic nitrogen double bonded at 2-position, or tautomeric equivalent

327
514/389

Divalent chalcogen or acyclic nitrogen double bonded directly at both 2- and 4- positions, or tautomeric equivalent (e.g., hydantoin, etc.)

254
514/391

Benzene ring bonded directly to the diazole ring by nonionic bonding

110
514/390

Chalcogen or nitrogen bonded directly at 1-, 3-, or 5-position by nonionic bonding

112
514/387

Polycyclo ring system having the diazole ring as one of the cyclos

260
514/388

Nitrogen double bonded directly at 2-position of the diazole ring, or tautomeric equivalent

179
514/396

Imidazoles

620
514/397

Additional hetero ring

1349
514/398

Chalcogen or nitrogen bonded directly to the imidazole ring by nonionic bonding

605
514/399

Chalcogen or nitrogen bonded indirectly to the imidazole ring by nonionic bonding

960
514/400

At imidazole ring carbon

776
514/393

Polycyclo ring system having the diazole ring as one of the cyclos

230
514/394

Benzo fused at 4,5-positions of the diazole ring

702
514/395

Chalcogen or nitrogen bonded directly at 1-, 2- or 3-position of the diazole ring by nonionic bonding

354
514/374

1,3-oxazoles (including hydrogenated)

1048
514/376

Chalcogen bonded directly to ring carbon of the oxazole ring

566
514/377

Nitrogen bonded directly to ring carbon of the oxazole ring

227
514/375

Polycyclo ring system having the oxazole ring as one of the cyclos

518
514/365

1,3-thiazoles (including hydrogenated)

1658
514/369

Chalcogen bonded directly to ring carbon of the thiazole ring

786
514/370

Nitrogen bonded directly to ring carbon of the thiazole ring

505
514/371

C=x bonded directly to the nitrogen which is bonded directly to the thiazole ring (x is chalcogen)

218
514/366

Polycyclo ring system having the thiazole ring as one of the cyclos

155
514/367

Bicyclo ring system having the thiazole ring as one of the cyclos

711
514/368

Ring nitrogen is shared by the cyclos of the bicyclo ring system (e.g., tetramisole, etc.)

138
514/360

Plural ring chalcogens in the hetero ring

127
514/361

Plural ring nitrogens and a single chalcogen in the hetero ring

376
514/362

1,2,5-thiadiazoles (including hydrogenated)

319
514/363

1,3,4-thiadiazoles (including hydrogenated)

453
514/364

Oxadiazoles (including hydrogenated)

604
514/381

Tetrazoles (including hydrogenated)

889
514/382

Additional chalcogen containing hetero ring

321
514/408

The five-membered hetero ring consists of one nitrogen and four carbons

539
514/422

Additional hetero ring

1587
514/423

C=x bonded directly to the five-membered hetero ring by nonionic bonding (x is chalcogen)

1223
514/429

Carbocyclic ring bonded directly to the five-membered hetero ring

211
514/424

Chalcogen bonded directly to the five-membered hetero ring by nonionic bonding

596
514/425

Plural chalcogens bonded directly to the five-membered hetero ring by nonionic bonding

284
514/428

Chalcogen bonded indirectly to the five-membered hetero ring by acyclic nonionic bonding

793
514/426

Nitrogen bonded directly to the five-membered hetero ring by nonionic bonding

242
514/410

Polycyclo ring system having the five-membered hetero ring as one of the cyclos

551
514/412

Bicyclo ring system having the five-membered hetero ring as one of the cyclos

338
514/414

Additional hetero ring which is not part of the bicyclo ring system

852
514/421

Chalcogen bonded directly to ring carbon of the five-membered hetero ring (e.g., adrenochrome, etc.)

152
514/413

Ring nitrogen is shared by the cyclos of the bicyclo ring system

183
514/415

The bicyclo ring system consists of the five-membered hetero ring and a benzene ring (e.g., indole, etc.)

1027
514/419

C=x bonded directly or indirectly by an acyclic carbon or carbon chain to ring carbon of the five-membered hetero ring (e.g., tryptophan, etc.) (x is chalcogen)

796
514/420

Indomethacine per se or ester thereof

179
514/418

Chalcogen bonded directly to ring carbon of the five-membered hetero ring

390
514/416

The ring nitrogen is bonded directly to nonshared ring carbons of the five-membered hetero ring (e.g., isoindole, etc.)

244
514/417

Plural chalcogens bonded directly to ring carbons of the five-membered hetero ring (e.g., phthalimide, etc.)

209
514/411

Tricyclo ring system having the five-membered hetero ring as one of the cyclos

724
514/409

Spiro ring system

267
514/427

Two double bonds between ring members of the five-membered hetero ring (e.g., pyrrole, etc.)

466
514/184

Heavy metal containing (including salts)

543
514/188

Hetero ring is six-membered consisting of one nitrogen and five carbons

241
514/190

Mercury

19
514/185

Polycyclo ring system

360
514/186

Bicyclo ring system

132
514/187

Quinolines or isoquinolines (including hydrogenated)

79
514/189

Tin

69
514/211.01

Hetero ring contains seven members including nitrogen, carbon and chalcogen

165
514/211.15

Additional nitrogen containing hetero ring attached directly or indirectly to the seven-membered hetero ring by nonionic bonding

280
514/211.03

Chalcogen double bonded directly to a ring carbon which is adjacent to the ring nitrogen

66
514/211.04

Polycyclo ring system which contains the seven-membered hetero ring as one of the cyclos

52
514/211.05

Bicyclo ring system having the seven-membered hetero ring as one of the cyclos

67
514/211.06

Ring chalcogen and ring nitrogen are in the 1,5-positions of the seven-membered hetero ring

37
514/211.07

Nitrogen attached directly or indirectly to the ring nitrogen of the seven-membered hetero ring by acyclic nonionic bonding (e.g., diltiazem, etc.)

106
514/211.02